MeSH tree: D12.776.543.750.750
For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity ...
Jan 6, 2026
0
9
Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic CV disease, according ...
Dec 30, 2025
0
16
Researchers at USF Health are making dramatic strides in understanding how new opioid compounds work inside the body to provide pain relief, offering greater hope that new classes of these drugs may eventually be used to ...
Dec 18, 2025
0
14
Private health insurance premiums will be going up in 2026—in some cases, by a lot.
Dec 16, 2025
0
24
Even when Americans have health insurance, they can have a hard time affording the drugs they've been prescribed.
Dec 16, 2025
0
6
No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating them with chemotherapy or radiation—which have undesirable side effects—what if we could train our ...
Dec 10, 2025
0
24
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published in Neurology.
Dec 10, 2025
0
14
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.
Dec 8, 2025
0
14
In a new paper published in Clinical Nutrition, "Sarcopenic Diabetes Is an Under-Recognized and Unmet Clinical Priority," nutrition and diabetes experts are calling attention to a little-known but serious complication of ...
Dec 1, 2025
0
18
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease associated with substantial morbidity, mortality, and economic burden.
Dec 1, 2025
0
25
